Barclays analyst Andrew Mok CFA has reaffirmed a Buy rating on UnitedHealth (UNH), setting a price target of $440.00. Mok, who focuses on the Healthcare sector, has an average return of -4.3% and a 51.54% success rate on recommended stocks according to TipRanks.
UnitedHealth has also received a Buy rating from Evercore ISI’s Elizabeth Anderson CFA in a recent report. However, TD Cowen maintained a Hold rating on the stock on October 9.
The company reported a quarterly revenue of $112.03 billion and a net profit of $5.48 billion for the quarter ending June 30. This compares to revenue of $111.62 billion and a net profit of $3.41 billion in the same period last year.
Despite positive analyst ratings, insider sentiment for UnitedHealth is negative. Over the past quarter, there has been an increase in insiders selling their shares. Most recently, CEO of Optum, Patrick Hugh Conway, sold 1,169 shares for a total of $455,910 in August 2026.